BECTON, DICKINSON AND COMPANY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Evaluation of a 4mmx32G Pen Needle for Injection of Basal Insulin Doses Above 40 Units

Not Applicable

Terminated

Conditions: Diabetes Mellitus, Type 2

Interventions: Device: 4 mm x 32G pen needle (Nano)
Device: 8mm x 31G pen needle (Short)

First Posted Date: 2011-04-13

Last Posted Date: 2022-03-10

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 21

Registration Number: NCT01334606

Locations: 🇺🇸
International Diabetes Center (IDC), Minneapolis, Minnesota, United States
🇺🇸
Comprehensive Clinical Research, Berlin, New Jersey, United States
🇨🇦
BioPharma Services Inc., Toronto, Ontario, Canada

Topical Antimicrobial Effectiveness Testing

Phase 4

Completed

Conditions: Antimicrobial Effectiveness

First Posted Date: 2011-03-14

Last Posted Date: 2012-11-01

Lead Sponsor: CareFusion

Target Recruit Count: 27

Registration Number: NCT01314703

Locations: 🇺🇸
Microbiotest, Sterling, Virginia, United States

Intended Use Study of the BD SurePath Plus™ Pap

Terminated

Conditions: Uterine Cervical Cancer
Neoplasms by Histologic Type
Papilloma
Neoplasms, Squamous Cell
Neoplasms
Uterine Cervical Neoplasms
Neoplasms, Glandular and Epithelial

Interventions: Device: BD SurePath Plus Pap test
Device: BD SurePath Pap test
Procedure: colposcopy with biopsy/ECC
Device: HPV DNA test

First Posted Date: 2010-11-04

Last Posted Date: 2023-05-16

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 5859

Registration Number: NCT01234480

Locations: 🇺🇸
Seattle Women's: Health, Research, Gynecology, Seattle, Washington, United States

Comparison of Glycemic Control in Obese Diabetics Using Three Different Pen Needles

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2

Interventions: Device: 4 mm x 32G Pen Needle
Device: 8mm x 31G Pen Needle
Device: 12.7mm x 29G Pen Needle

First Posted Date: 2010-11-02

Last Posted Date: 2014-06-27

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 293

Registration Number: NCT01231984

Locations: 🇺🇸
AMCR Institute, Inc., Escondido, California, United States
🇺🇸
Atlanta Diabetes Associates, Atlanta, Georgia, United States
🇺🇸
Springfield Diabetes and Endocrine Center, Springfield, Illinois, United States

and more 7 locations

Study on the Effects on Blood Glucose Following Intradermal and Subcutaneous Dosing of Insulin in Diabetic Patients

Phase 1

Completed

Conditions: Diabetes

Interventions: Device: Subcutaneous delivery of insulin using Disetronic Accu-Chek Rapid D infusion set
Device: BD Research Catheter with 34G x 1.5 mm needle

First Posted Date: 2010-05-11

Last Posted Date: 2011-04-18

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 20

Registration Number: NCT01120444

Locations: 🇩🇪
Profil Institute of Clinical Research, Neuss, Germany

Components of Chlorhexidine Gluconate Dressing

Phase 1

Completed

Conditions: Healthy

Interventions: Device: Biopatch
Device: CHG Catheter Dressing Patch
Device: Tegaderm CHG

First Posted Date: 2010-04-28

Last Posted Date: 2013-03-22

Lead Sponsor: CareFusion

Target Recruit Count: 45

Registration Number: NCT01112020

Locations: 🇺🇸
Cetero Research, St. Charles, Missouri, United States

A Comparison Study of Prototype Continuous Glucose Sensors in the Intradermal and Subcutaneous Spaces

Phase 1

Completed

Conditions: Diabetes

Interventions: Device: BD Continuous glucose monitor (BD CGM)
Device: YSI Glucose Analyzer
Device: Medtronic Guardian CGM

First Posted Date: 2010-03-26

Last Posted Date: 2016-05-06

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 40

Registration Number: NCT01093833

Locations: 🇺🇸
Profil Institute for Clinical Research Inc, Chula Vista, California, United States

Pharmacokinetics/Dynamics of Basal (Continuous) Insulin Infusion Administered Either Intradermally or Subcutaneously

Phase 1

Completed

Conditions: Diabetes Mellitus, Type 2
Diabetes Mellitus, Type 1

First Posted Date: 2010-02-03

Last Posted Date: 2010-03-10

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 20

Registration Number: NCT01061216

Locations: 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany

Comparison of Glycemic Control Among Diabetics Using Three Different Pen Needles

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2

Interventions: Device: 4mm x 32G pen needle
Device: 8mm x 31G pen needle
Device: 5mm x 31G pen needle

First Posted Date: 2009-06-25

Last Posted Date: 2010-10-20

Lead Sponsor: Becton, Dickinson and Company

Target Recruit Count: 173

Registration Number: NCT00928057

Locations: 🇺🇸
AMCR Institute, Inc., Escondido, California, United States
🇺🇸
Rainier Clinical Research Center, Inc., Renton, Washington, United States
🇺🇸
Atlanta Diabetes Associates, Atlanta, Georgia, United States

and more 1 locations

Test for Pre Operative Skin Preparations

Phase 3

Completed

Conditions: Topical Antisepsis

Interventions: Other: Sterile swabstick with sterile water (3 @ once)
Drug: CHG 2% w/v & IPA 70% v/v, swabstick (3 @ once).
Drug: CHG 2% w/v & IPA 70% v/v swab applied sequentially
Drug: Aqueous CHG 4% w/v applied according to mfr's directions
Other: Sterile swabstick with sterile water (one-at-a-time)

First Posted Date: 2008-12-01

Last Posted Date: 2021-05-27

Lead Sponsor: CareFusion

Target Recruit Count: 335

Registration Number: NCT00799812

Locations: 🇺🇸
Microbiotest, Sterling, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy